In our study, CRC patients showed significantly higher serum levels of TNF-α and IL-1β compared to controls, consistent with findings from previous studies conducted in Brazil [15], Poland [16], and Romania [17], which also reported elevated levels of these cytokines in CRC patients. The gene discussed is TNF; the disease is colorectal carcinoma.